BRD2 and neoplasm: The enriched EMT pathway in the new subtype ‘EMT-E’ reported in the original publication [45] was also found altered in the comparison between Tumor and NAT, which suggested that the altered proteins in the EMT pathway could be further investigated as potential biomarkers for diagnosis as well as prognosis.